SIG Sessions

SATURDAY JULY 9

2000-2200

Concurrent Special Interest Group (SIG) Sessions

 

 

MONDAY JULY 11

2000-2200

Concurrent Special Interest Group (SIG) Sessions

 

Gynecological Pathology Special Interest Group
Saturday July 9, 2000-2200

 

Objectives:

At the end of this session, participants will be able to:

  • Identify those results from The Cancer Genome Atlas that make it possible to now offer a genomic-based classification of endometrial carcinoma.
  • Describe the clinical and pathological features of endometrial cancers with POLE mutations.
  • List the molecular features that define the dedifferentiated/undifferentiated group of endometrial carcinomas.

2000-2005

Welcome

2005-2050

Towards molecular subclassification of endometrial carcinoma

Lien Hoang, Memorial Sloan Kettering Cancer Center

2050-2100

Discussion

2100-2120

POLE mutant endometrial carcinomas: histopathological features and outcomes

Mary Kinloch, University of Saskatchewan

2120-2130

Discussion

2130-2155

Dedifferentiated/Undifferentiated endometrial carcinoma: the molecular basis of an aggressive endometrial carcinoma variant distinct from serous or clear cell carcinoma

Chenghan Lee, University of Alberta

2155-2200

Discussion

Back to top

 

Nephropathology Special Interest Group
Saturday July 9, 2000-2200

1.

Approval of agenda

2.

Approval of minutes, June 20, 2015

3.

Website

4.

Guidelines

5.

Collaboration with CSN

  1. Education
  2. Registry

6.

Other business

  1. EQA Program
  2. Diploma Program
  3. Banff Classification

7.

Interesting cases

8.

Next meeting: Charlottetown, 2017

9.

Adjournment

Back to top

 

Canadian Network of Uropathology
Monday July 11, 2000-2200

2000-2015

Spindle Cell Tumors of the Kidney

George M. Yousef, University of Toronto

2015-2020

Discussion

2020-2035

The Gamut of Neuroendocrine Differentiation in Prostate Cancer

Theodorus H. Van der Kwast, Princess Margaret Cancer Center, University Health Network

2035-2040

Discussion

2040-2055

New Molecular Subtypes of Bladder Cancer

David Berman, Queen’s University, Queen’s Cancer Research Institute

2055-2100

Discussion

2100-2110

Break

2110-2125

What is new in Testis Pathology?

Asli Yilmaz , Calgary Laboratory Services

2125-2130

Discussion

2130-2200

Open CNUP Discussions

Back to top

 

Evidence Based Medicine Special Interest Group – Bits and Bites of Evidence-Based Medicine for Practicing Pathologist
Monday July 11, 2000-2200

The Diagnostic Accuracy Question and PIRATES

Mary Anne Brett, McMaster University

Do We Understand Diagnostic Accuracy?

Nick Myles, Providence Health Care / University of British Columbia

Accuracy vs Reproducibility: If you don’t agree, does that mean you are wrong?

Mary Anne Brett, McMaster University

How Do I Take a Section of THAT?!? – Medical Devices, Pathology, and Quality Assurance

Michael A. Seidman, Providence Health Care / University of British Columbia

Number Needed To Harm: A case of radiation induces angiosarcoma

Kennry Chiu, University of British Columbia

Making Likelihood Ratios of Use: Bethesda System for Thyroid Cytology

Emilia Todorovic, University of British Columbia

Libre Pathology: Disseminating Evidence-Based Pathology Information

Michael Bonert, McMaster University

Expanded Evidence: Levels of Truth

J. Fergall Magee, University of Saskatchewan

All CAP-ACP Members, irrespective whether they are SIG members or not, are welcome to attend!

Back to top

 

General Pathology Special Interest Group
Monday July 11, 2000-2200

 

The discussion will focus on planning for the development of a new section for GP and to solicit feedback from interested parties as to how to structure this new group.

Download the Terms of Reference of the New GP Section

Download the GP Section Presentation

Back to top